Catalyst Pharmaceuticals Set to Join S&P SmallCap 600

Catalyst Pharmaceuticals Set to Join S&P SmallCap 600

NEW YORK, Sept. 12, 2022 /PRNewswire/ — Catalyst Pharmaceuticals Inc. (NASD: CPRX) will replace Mantech International Corp. (NASD: MANT) in the S&P SmallCap 600 effective prior to the opening of trading on Thursday, September 15. The Carlyle Group Inc. (NASD: CG) is acquiring ManTech International in a transaction expected to be completed soon pending final conditions.

Following is a summary of the changes that will take place prior to the open of trading on the effective date:

Effective Date


Source link

About search

Check Also

Stock market today: Dow touches 40,000 as stocks hover at record highs – Yahoo Finance

Stock market today: Dow touches 40,000 as stocks hover at record highs – Yahoo Finance

[unable to retrieve full-text content]Stock market today: Dow touches 40,000 as stocks hover at record …

Leave a Reply

Your email address will not be published. Required fields are marked *